Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
52 Cards in this Set
- Front
- Back
Histamine acts on:
|
Small diameter sensory neurons
|
|
Three modalities transmitted by small diameter sensory neurons
|
Temperature
Noxious Itch |
|
Histamine is decarboxylatd from:
|
Histidine
|
|
Histamine is synthesized and stored in:
|
Mast cells
Enterochromaffin cells |
|
Two main histamine receptors
|
H1 and H2
|
|
H1 Receptor
|
Smooth muscle
Vascular endothelium Brain |
|
H2 Receptor
|
Gastric mucosa
Cardiac muscle Brain |
|
Use of H1 Agonist
|
Test for bronchosensitivity
|
|
H1 Agonist - Name 3
|
2-methylhistamine
Histamine 2-(3-Bromphenyl) |
|
H1 Receptor Antagonist - 1st generation (name 2)
|
Diphenhydranine
Chlorpheniramine |
|
H1 Receptor Antagonist - 2nd generation (name 4)
|
Cetirizine
Loratidine Desloratadine Fexofenadine |
|
H2 Receptor Antagonist (Name 4)
|
Cimetidine
Famotidine Ranitidine Nizatidine |
|
Use for H2 Receptor Antagonist
|
Treat PUD and gastric irritation
|
|
6 major physiologic actions of histamine
|
1. Allergic response
2. CV effects 3. Bronchoconstriction 4. Increase in gastric acid secretion (H2) 5. Itch 6. Anaphylaxis |
|
Allergic response mediated by histamine
|
Rhinitis and urticaria (hives)
|
|
Cardiovascular effects mediated by histamine
|
Vasodilation
Increased vascular permeability Histamine injection triple response (red spot, flare, wheal) Increased contraction of heart |
|
Anaphylaxis
|
Severe hypotension
Bronchoconstriction Epiglottal swelling |
|
Antihistamine are/are not effective in treating bronchoconstriction.
|
Not effective
|
|
Type of antagonist of H1 Antagonists
|
Reversible, competitive inhibitor
|
|
Properties of first generation H1 Antagonist
|
1. Highly lipid soluble
2. Drowsiness and sedation 3. Some anti-muscarinic activity |
|
Why use 1st generation H1 antagonist in sleep aids
|
Highly lipid soluble - readily distribute to CNS
Produce drowsiness and sedation |
|
Why use 1st generation H1 antagonist in first line treatment of Parkinson's
|
Some antimuscarinic activity can help with early manifestations of Parkinsons
|
|
Properties of 2nd generation H1 Antagonist
|
1. Ionized at pH 7.4 - less readily into CNS
2. Highly bound to albumin - less readily into CNS 3. Less drowsiness and sedation 4. No antimuscarinic activity |
|
Name 6 1st generation H1 Antagonist
|
1. Diphenhydramine
2. Chlorpheniramine 3. Pyrilamine 4. Hydroxyzine 5. Promethazine 6. Doxepin |
|
Major side effect of 1st generation H1 Antagonist
|
Drowsiness and sedation
|
|
Name four 2nd generation H1 antagonist
|
Cetirizine
Loratadine Desloratadine Fexofenadine |
|
2nd generation H1 antagonists metabolism
|
CYP450 pathway
Consider drug drug interactions of those also metabolized by CYP450 |
|
Do/do not get anticholinergic effects w/ 2nd generation H1 antagonist
|
Don't get anticholinergic effects
|
|
Difference in side effects between 1st and 2nd generation H1 antagonist
|
2nd generation = minimal drowsiness and sedation
|
|
Use for promethazine
|
Treatment of nausea and vomiting
Antimuscarinic effects |
|
Use for diphenhydramine aside from OTC use
|
First line treatment of Parkinsons disease
Antimuscarinic effects |
|
Two 1st generation antihistamines used for prophylaxis and treatment of motion sickness
|
Promethazine and diphenhydramine
|
|
5HT is derived from which amino acid
|
Tryptophan
|
|
Name two important 5HT receptor subtypes
|
5HT1B, 5HT1D
|
|
Function of 5HT1B Receptor
|
Autoreceptor
Regulate presynaptic function |
|
Function of 5HT1D Receptor
|
Vasoconstriction
|
|
Ergot alkaloids act on which 5HT receptor subtype
|
5HT2A, 5HT2B
|
|
Function of 5HT2 Receptor
|
Smooth muscle contraction
(Think uterine SM contraction) |
|
Prophylaxis of migraine
|
Beta-blocker
TCA |
|
4 Characteristics of Migraine
|
1. Unilateral HA lasting 4-72 hours
2. Pulsating and aggravated by movement 3. Nausea or photophobia 4. Preceded by visual aura (commonly) |
|
Rx therapy for migraine
|
5HT1B/5HT1D Agonist
|
|
Disorder of neurogenic inflammation
|
Migraine
|
|
Neurogenic inflammation of migraine mediated by:
|
CT gene related peptide (CGRP)
Substance P |
|
Three possible components of Migraine
|
1. Neurogenic inflammation
2. Cortical speading depression 3. Central sensitization |
|
Triptans
|
5HT1 receptor agonist
|
|
Name 5 triptans (5HT1 receptor agonist)
|
sumatriptan
naratriptan rizatriptan Zolmitriptan Almotriptan |
|
Where do triptans work?
|
5HT1 receptors especially 5HT1B AND 5HT1D
|
|
Triptans are/are not useful in prophylaxis and long term use in treatment of migraines
|
Not useful
|
|
2 Proposed mechanisms of action of triptans on migraines
|
1. Direct vascoconstriction of intracranial blood vessels 5HT1D)
2. Presynaptic inhibition on sensory neurons (5HT1B) |
|
Rare complication of triptans
|
Serious CV complications:
Coronary artery spasm (due to SM constriction, activation of 5HT2R)--> ischemia, arrhythmia |
|
Contraindication to triptans
|
History of ischemic/vasospastic coronary artery disease
Cerebrovascular or peripheral vascular disease Uncontrolled HT Patients on MAO-I |
|
Do not give naratriptan to:
|
Patients with severe renal or hepatic disease
|